Endo Health Rises On Unusually High Volume (ENDP)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Endo Health Solutions (Nasdaq: ENDP) is trading at unusually high volume Wednesday with 5.1 million shares changing hands. It is currently at two times its average daily volume and trading up $1.33 (+4.2%) at $33.27 as of 3:51 p.m. ET.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Endo Health has a market cap of $3.41 billion and is part of the health care sector and drugs industry. Shares are up 21.8% year to date as of the close of trading on Tuesday.

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally.

TheStreet Ratings rates Endo Health as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. You can view the full Endo Health Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

Why Hospitals Shouldn't Terrify Generic Drug Companies

Why Hospitals Shouldn't Terrify Generic Drug Companies

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear